Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Simple Bioreactor-Based Method to Generate Kidney Organoids from Pluripotent Stem Cells.
Stem Cell Reports. 2018 Aug 14;11(2):470-484. doi: 10.1016/j.stemcr.2018.06.018. Epub 2018 Jul 19.
Stem Cell Reports. 2018.
PMID: 30033089
Free PMC article.
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma.
Tran KB, Gimenez G, Tsai P, Kolekar S, Rodger EJ, Chatterjee A, Jabed A, Shih JH, Joseph WR, Marshall ES, Wang Q, Print CG, Eccles MR, Baguley BC, Shepherd PR.
Tran KB, et al. Among authors: shih jh.
Pigment Cell Melanoma Res. 2021 Jan;34(1):136-143. doi: 10.1111/pcmr.12908. Epub 2020 Jul 4.
Pigment Cell Melanoma Res. 2021.
PMID: 32567790
Free PMC article.
Item in Clipboard
Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK.
Tran KB, Kolekar S, Jabed A, Jaynes P, Shih JH, Wang Q, Flanagan JU, Rewcastle GW, Baguley BC, Shepherd PR.
Tran KB, et al. Among authors: shih jh.
BMC Cancer. 2021 Feb 6;21(1):136. doi: 10.1186/s12885-021-07826-4.
BMC Cancer. 2021.
PMID: 33549048
Free PMC article.
Item in Clipboard
Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models.
Tran KB, Kolekar S, Wang Q, Shih JH, Buchanan CM, Deva S, Shepherd PR.
Tran KB, et al. Among authors: shih jh.
Mol Cancer Ther. 2022 Dec 2;21(12):1777-1787. doi: 10.1158/1535-7163.MCT-21-0941.
Mol Cancer Ther. 2022.
PMID: 36198029
Free PMC article.
Item in Clipboard
DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular.
Buchanan CM, Shih JH, Astin JW, Rewcastle GW, Flanagan JU, Crosier PS, Shepherd PR.
Buchanan CM, et al. Among authors: shih jh.
Clin Sci (Lond). 2012 May 1;122(10):449-57. doi: 10.1042/CS20110412.
Clin Sci (Lond). 2012.
PMID: 22142330
Item in Clipboard
Cite
Cite